Soleno Therapeutics Inc (SLNO)

Other Income/Expenses (Net)

$3.15M

Quarterly · Period ending: · USD

SLNO logo

SLNO Other Income/Expenses (Net)

Latest reported$3.15M
SLNO Quarterly Other Income/Expenses (Net) (-$867.21K → $3.15M)
High-resolution chart · PNG

SLNO other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
3,151,000
2,927,000
3,908,000
1,817,000
1,970,000
3,134,000
3,596,000
1,377,000
2,077,000
2,614,000
-479,000
148,000
113,000
124,000
103,000
54,000
49,000
173,000
146,000
97,000
-18,110,000
5,105,000
-688,000
3,809,000
-15,140,000
-7,745,000
7,022,000
-4,385,000
-2,052,000
3,928,000
1,569,000
-3,222,000
185,000
-932,480
139,000
-271,000
-677,000
-758,883
1,164,000
-72,000
1,074,000
662,200
-110,000
4,925,000
-9,225,000
-6,009,784
-1,070,000
-1,486,000
-149,865
-414,460
-597,000
-981,000
-867,213
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.